Stoke Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
20.03.26
/
50%
€28.40
Target price
20.03.27
€51.88
Performance (%)
-8.98%
Price
17.07.26
€25.36
Summary
This prediction is currently active. With a performance of -8.98%, the BUY prediction by Canaccord_Genuity_Gr is trending in the wrong direction. This prediction currently runs until 20.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target raised by Canaccord Genuity Group Inc. from $36.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.85
28.04.23
28.04.23
€21.78
28.04.24
28.04.24
28.81%
29.04.24
29.04.24
